Covid-19 roundup: J&J files for emergency use authorization of its Covid-19 vaccine
Covid-19 roundup: J&J files for emergency use authorization of its vaccine ⋮ A study finds the Covid-19 vaccine developed in Russia is 92% effective, research indicates Eli Lilly's monoclonal antibody treatment for Covid-19 is ineffective against a coronavirus variant first discovered in South Africa, and more. Johnson & Johnson (J&J) on Thursday asked FDA for an emergency use authorization of its Covid-19 vaccine candidate. The move comes shortly after J&J last week released findings from a Phase III clinical trial demonstrating that just one dose of the vaccine candidate was 66% eff...
Source: advisory.com